1 2637 41 YOGA FOR TREATMENT OF URINARY INCONTINENCE IN WOMEN. THIS IS A PROTOCOL FOR A COCHRANE REVIEW (INTERVENTION). THE OBJECTIVES ARE AS FOLLOWS: TO ASSESS THE EFFECTIVENESS AND SAFETY OF YOGA FOR TREATMENT OF URINARY INCONTINENCE IN WOMEN, COMPARED TO NO SPECIFIC TREATMENT, TO ANOTHER ACTIVE TREATMENT, OR TO AN ACTIVE TREATMENT WITHOUT ADJUVANT YOGA, WITH A FOCUS ON PATIENT SYMPTOMS AND QUALITY OF LIFE. 2017 2 1543 19 KUNDALINI YOGA FOR GENERALIZED ANXIETY DISORDER: AN EXPLORATION OF TREATMENT EFFICACY AND POSSIBLE MECHANISMS. THE AIM OF THIS STUDY WAS TO EXAMINE THE EFFICACY OF KUNDALINI YOGA IN REDUCING SYMPTOMS OF GENERALIZED ANXIETY DISORDER (GAD) COMPARED TO A COMMON TREATMENT-AS-USUAL CONDITION USING COGNITIVE TECHNIQUES. A SECONDARY OBJECTIVE WAS TO EXPLORE POTENTIAL TREATMENT MECHANISMS. FEMALES AGED 24 TO 75 YEARS WITH GAD ( N = 49) RECEIVED EITHER AN 8-WEEK KUNDALINI YOGA INTERVENTION ( N = 34) OR AN 8-WEEK TREATMENT-AS-USUAL CONDITION ( N = 15). THE YOGA CONDITION RESULTED IN LOWER LEVELS OF ANXIETY RELATIVE TO THE TREATMENT-AS-USUAL CONDITION. FURTHERMORE, CHANGES IN SOMATIC SYMPTOMS MEDIATED TREATMENT OUTCOME FOR KUNDALINI YOGA. KUNDALINI YOGA MAY SHOW PROMISE AS A TREATMENT FOR GAD, AND THIS TREATMENT MIGHT CONVEY ITS EFFECT ON SYMPTOM SEVERITY BY REDUCING SOMATIC SYMPTOMS. 2018 3 2023 23 SYSTEMATIC REVIEW OF YOGA FOR SYMPTOM MANAGEMENT DURING CONVENTIONAL TREATMENT OF BREAST CANCER PATIENTS. INTRODUCTION: BREAST CANCER IS ONE OF THE MOST COMMONLY DIAGNOSED CANCERS IN WOMEN IN THE US, AND ITS TREATMENTS HAVE SIGNIFICANT PHYSICAL AND PSYCHOLOGICAL SIDE EFFECTS AND LONG-TERM COMPLICATIONS CAUSING SIGNIFICANT MORBIDITY AND DECREASED QUALITY OF LIFE. INTEGRATIVE MEDICINE MODALITIES, SUCH AS YOGA, HAVE BEEN FOUND TO REDUCE SIDE EFFECTS OF CONVENTIONAL TREATMENTS WITHOUT INTERFERING WITH THE TREATMENT ITSELF AND IMPROVE QUALITY OF LIFE. IN THIS SYSTEMATIC REVIEW, WE SPECIFICALLY EXPLORED YOGA AS A POTENTIAL OPTION FOR SYMPTOMATIC MANAGEMENT IN PATIENTS UNDERGOING CONVENTIONAL BREAST CANCER TREATMENTS. METHODS: WE PERFORMED A LITERATURE SEARCH THAT WAS CONDUCTED TO INCLUDE THE DATABASES PUBMED, PSYCHINFO, COCHRANE LIBRARY, SCOPUS, AND CINAHL, RESULTING IN 28 RANDOMIZED CONTROLLED TRIAL (RCT) ARTICLES. WE REVIEW THE RESULTS OF THESE TRIALS REGARDING THE IMPACT OF YOGA IN THIS PATIENT POPULATION. RESULTS: OVERALL, THE MAJORITY OF THE RCT ARTICLES SHOWED SIGNIFICANT BENEFITS OF YOGA INTERVENTION IN VARIOUS ASPECTS OF QUALITY OF LIFE, FATIGUE, NAUSEA/VOMITING, SLEEP QUALITY, ANXIETY, DEPRESSION, AND DISTRESS. THERE ARE SEVERAL STUDIES THAT HAVE EXPLORED THE PHYSIOLOGICAL MECHANISM BEHIND THE EFFECTS OF YOGA AND FOUND THAT YOGA AFFECTS BOTH THE IMMUNE RESPONSE AND INFLAMMATION. DISCUSSION: THESE STUDIES REVEALED THAT YOGA HAS A POTENTIAL THERAPEUTIC ROLE IN THE SYMPTOMATIC MANAGEMENT OF BREAST CANCER PATIENTS, ENHANCING QUALITY OF LIFE DURING TREATMENT AS WELL AS IMPROVING ADHERENCE TO TREATMENT. FUTURE STUDIES WITH MORE DEFINED AND CONSISTENT METHODOLOGIES ARE NECESSARY TO FULLY UNDERSTAND THE POTENTIAL USE OF YOGA THERAPY IN PATIENTS WITH BREAST CANCER. 2022 4 1556 21 LONG-TERM CHANGES OF SYMPTOMS OF ANXIETY, DEPRESSION, AND FATIGUE IN CANCER PATIENTS 6 MONTHS AFTER THE END OF YOGA THERAPY. BACKGROUND: SYMPTOMS OF ANXIETY, DEPRESSION, AND CANCER-RELATED FATIGUE ARE COMMONLY ASSOCIATED WITH CANCER. CANCER PATIENTS INCREASINGLY USE COMPLEMENTARY AND ALTERNATIVE TREATMENTS, SUCH AS YOGA, TO COPE WITH PSYCHOLOGICAL AND PHYSICAL IMPAIRMENTS. IN THE PRESENT ARTICLE, LONG-TERM CHANGES OF ANXIETY, DEPRESSION, AND FATIGUE IN CANCER ARE EXAMINED 6 MONTHS AFTER A YOGA INTERVENTION. METHOD: WE USED AN OBSERVATIONAL DESIGN BASED ON A RANDOMIZED CONTROLLED STUDY IN CANCER PATIENTS WITH MIXED DIAGNOSES TO EVALUATE LONG-TERM CHANGES OF SYMPTOMS OF ANXIETY, DEPRESSION, AND FATIGUE 6 MONTHS AFTER THE END OF YOGA THERAPY. WE MEASURED ANXIETY SYMPTOMS WITH THE GENERALIZED ANXIETY DISORDER SCALE (GAD-7), DEPRESSIVE SYMPTOMS WITH THE PATIENT HEALTH QUESTIONNAIRE-2 (PHQ-2), AND FATIGUE WITH THE EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER QUALITY OF LIFE QUESTIONNAIRE-FATIGUE SCALE (EORTC QLQ-FA13). YOGA THERAPY WAS PROVIDED IN YOGA CLASSES OF 60 MINUTES EACH ONCE A WEEK FOR 8 WEEKS IN TOTAL. THE EXERCISES PROVIDED CONTAINED BOTH BODY AND BREATHING ACTIVITIES AS WELL AS MEDITATION. RESULTS: A TOTAL OF 58 PATIENTS PARTICIPATED IN THE STUDY. SIX MONTHS AFTER THE END OF YOGA THERAPY, SYMPTOMS OF ANXIETY, DEPRESSION, AND FATIGUE WERE SIGNIFICANTLY REDUCED COMPARED WITH BASELINE. HOWEVER, SYMPTOMS OF ANXIETY AND FATIGUE SLIGHTLY INCREASED DURING THE FOLLOW-UP PERIOD, WHEREAS SYMPTOMS OF DEPRESSION REMAINED STABLE. CONCLUSION: OUR RESULTS ARE PROMISING AND SUPPORT THE INTEGRATION OF YOGA INTERVENTIONS IN SUPPORTIVE CANCER TREATMENT CONCEPTS BUT SHOULD BE CONFIRMED BY RANDOMIZED CONTROLLED TRIALS. LONG-TERM EFFECTS OF YOGA THERAPY ON CANCER PATIENTS SHOULD BE THE SUBJECT OF FURTHER RESEARCH. 2019 5 2688 22 YOGA IN THE TREATMENT OF MOOD AND ANXIETY DISORDERS: A REVIEW. BACKGROUND: PATIENT USE OF COMPLEMENTARY AND ALTERNATIVE TREATMENTS, INCLUDING YOGA, TO MANAGE MOOD AND ANXIETY DISORDERS, HAS BEEN WELL DOCUMENTED. DESPITE RESEARCH INTEREST, THERE ARE FEW RECENT REVIEWS OF THE EVIDENCE OF THE BENEFIT OF YOGA IN THESE CONDITIONS. METHOD: THE PUBMED, MEDLINE AND PSYCINFO DATABASES WERE SEARCHED FOR LITERATURE PUBLISHED UP TO JULY 2008, RELATING TO YOGA AND DEPRESSIVE AND ANXIETY DISORDERS. RESULTS: THE PAUCITY OF REPORTED STUDIES AND SEVERAL METHODOLOGICAL CONSTRAINTS LIMIT DATA INTERPRETATION. IN DEPRESSIVE DISORDERS, YOGA MAY BE COMPARABLE TO MEDICATION AND THE COMBINATION SUPERIOR TO MEDICATION ALONE. THERE IS REASONABLE EVIDENCE FOR ITS USE AS SECOND-LINE MONOTHERAPY OR AUGMENTATION TO MEDICATION IN MILD TO MODERATE MAJOR DEPRESSION AND DYSTHYMIA, WITH EARLY EVIDENCE OF BENEFIT IN MORE SEVERE DEPRESSION. IN ANXIETY DISORDERS, YOGA MAY BE SUPERIOR TO MEDICATION FOR A SUBGROUP OF PATIENTS, BUT ITS BENEFITS IN SPECIFIC CONDITIONS ARE STILL LARGELY UNKNOWN. SECOND-LINE MONOTHERAPY IS INDICATED IN PERFORMANCE OR TEST ANXIETY, BUT ONLY PRELIMINARY EVIDENCE EXISTS FOR OBSESSIVE-COMPULSIVE DISORDER AND POST-TRAUMATIC STRESS DISORDER. YOGA APPEARS TO BE SUPERIOR TO NO TREATMENT AND PROGRESSIVE RELAXATION FOR BOTH DEPRESSION AND ANXIETY, AND MAY BENEFIT MOOD AND ANXIETY SYMPTOMS ASSOCIATED WITH MEDICAL ILLNESS. IT SHOWS GOOD SAFETY AND TOLERABILITY IN SHORT-TERM TREATMENT. CONCLUSION: REASONABLE EVIDENCE SUPPORTS THE BENEFIT OF YOGA IN SPECIFIC DEPRESSIVE DISORDERS. THE EVIDENCE IS STILL PRELIMINARY IN ANXIETY DISORDERS. GIVEN ITS PATIENT APPEAL AND THE PROMISING FINDINGS THUS FAR, FURTHER RESEARCH ON YOGA IN THESE CONDITIONS IS ENCOURAGED. 2009 6 576 17 DEPRESSION AND ANXIETY DISORDERS: BENEFITS OF EXERCISE, YOGA, AND MEDITATION. MANY PEOPLE WITH DEPRESSION OR ANXIETY TURN TO NONPHARMACOLOGIC AND NONCONVENTIONAL INTERVENTIONS, INCLUDING EXERCISE, YOGA, MEDITATION, TAI CHI, OR QI GONG. META-ANALYSES AND SYSTEMATIC REVIEWS HAVE SHOWN THAT THESE INTERVENTIONS CAN IMPROVE SYMPTOMS OF DEPRESSION AND ANXIETY DISORDERS. AS AN ADJUNCTIVE TREATMENT, EXERCISE SEEMS MOST HELPFUL FOR TREATMENT-RESISTANT DEPRESSION, UNIPOLAR DEPRESSION, AND POSTTRAUMATIC STRESS DISORDER. YOGA AS MONOTHERAPY OR ADJUNCTIVE THERAPY SHOWS POSITIVE EFFECTS, PARTICULARLY FOR DEPRESSION. AS AN ADJUNCTIVE THERAPY, IT FACILITATES TREATMENT OF ANXIETY DISORDERS, PARTICULARLY PANIC DISORDER. TAI CHI AND QI GONG MAY BE HELPFUL AS ADJUNCTIVE THERAPIES FOR DEPRESSION, BUT EFFECTS ARE INCONSISTENT. AS MONOTHERAPY OR AN ADJUNCTIVE THERAPY, MINDFULNESS-BASED MEDITATION HAS POSITIVE EFFECTS ON DEPRESSION, AND ITS EFFECTS CAN LAST FOR SIX MONTHS OR MORE. ALTHOUGH POSITIVE FINDINGS ARE LESS COMMON IN PEOPLE WITH ANXIETY DISORDERS, THE EVIDENCE SUPPORTS ADJUNCTIVE USE. THERE ARE NO APPARENT NEGATIVE EFFECTS OF MINDFULNESS-BASED INTERVENTIONS, AND THEIR GENERAL HEALTH BENEFITS JUSTIFY THEIR USE AS ADJUNCTIVE THERAPY FOR PATIENTS WITH DEPRESSION AND ANXIETY DISORDERS. 2019 7 2638 18 YOGA FOR VETERANS WITH CHRONIC LOW BACK PAIN: DESIGN AND METHODS OF A RANDOMIZED CLINICAL TRIAL. CHRONIC LOW BACK PAIN (CLBP) AFFLICTS MILLIONS OF PEOPLE WORLDWIDE, WITH PARTICULARLY HIGH PREVALENCE IN MILITARY VETERANS. MANY TREATMENT OPTIONS EXIST FOR CLBP, BUT MOST HAVE LIMITED EFFECTIVENESS AND SOME HAVE SIGNIFICANT SIDE EFFECTS. IN GENERAL POPULATIONS WITH CLBP, YOGA HAS BEEN SHOWN TO IMPROVE HEALTH OUTCOMES WITH FEW SIDE EFFECTS. HOWEVER, YOGA HAS NOT BEEN ADEQUATELY STUDIED IN MILITARY VETERAN POPULATIONS. IN THE CURRENT PAPER WE WILL DESCRIBE THE DESIGN AND METHODS OF A RANDOMIZED CLINICAL TRIAL AIMED AT EXAMINING WHETHER YOGA CAN EFFECTIVELY REDUCE DISABILITY AND PAIN IN US MILITARY VETERANS WITH CLBP. A TOTAL OF 144 US MILITARY VETERANS WITH CLBP WILL BE RANDOMIZED TO EITHER YOGA OR A DELAYED TREATMENT COMPARISON GROUP. THE YOGA INTERVENTION WILL CONSIST OF 2X WEEKLY YOGA CLASSES FOR 12WEEKS, COMPLEMENTED BY REGULAR HOME PRACTICE GUIDED BY A MANUAL. THE DELAYED TREATMENT GROUP WILL RECEIVE THE SAME INTERVENTION AFTER SIX MONTHS. THE PRIMARY OUTCOME IS THE CHANGE IN BACK PAIN-RELATED DISABILITY MEASURED WITH THE ROLAND-MORRIS DISABILITY QUESTIONNAIRE AT BASELINE AND 12-WEEKS. SECONDARY OUTCOMES INCLUDE PAIN INTENSITY, PAIN INTERFERENCE, DEPRESSION, ANXIETY, FATIGUE/ENERGY, QUALITY OF LIFE, SELF-EFFICACY, SLEEP QUALITY, AND MEDICATION USAGE. ADDITIONAL PROCESS AND/OR MEDIATIONAL FACTORS WILL BE MEASURED TO EXAMINE DOSE RESPONSE AND EFFECT MECHANISMS. ASSESSMENTS WILL BE CONDUCTED AT BASELINE, 6-WEEKS, 12-WEEKS, AND 6-MONTHS. ALL RANDOMIZED PARTICIPANTS WILL BE INCLUDED IN INTENTION-TO-TREAT ANALYSES. STUDY RESULTS WILL PROVIDE MUCH NEEDED EVIDENCE ON THE FEASIBILITY AND EFFECTIVENESS OF YOGA AS A THERAPEUTIC MODALITY FOR THE TREATMENT OF CLBP IN US MILITARY VETERANS. 2016 8 2623 20 YOGA FOR SYMPTOM MANAGEMENT IN ONCOLOGY: A REVIEW OF THE EVIDENCE BASE AND FUTURE DIRECTIONS FOR RESEARCH. BECAUSE YOGA IS INCREASINGLY RECOGNIZED AS A COMPLEMENTARY APPROACH TO CANCER SYMPTOM MANAGEMENT, PATIENTS/SURVIVORS AND PROVIDERS NEED TO UNDERSTAND ITS POTENTIAL BENEFITS AND LIMITATIONS BOTH DURING AND AFTER TREATMENT. THE AUTHORS REVIEWED RANDOMIZED CONTROLLED TRIALS (RCTS) OF YOGA CONDUCTED AT THESE POINTS IN THE CANCER CONTINUUM (N = 29; N = 13 DURING TREATMENT, N = 12 POST-TREATMENT, AND N = 4 WITH MIXED SAMPLES). FINDINGS BOTH DURING AND AFTER TREATMENT DEMONSTRATED THE EFFICACY OF YOGA TO IMPROVE OVERALL QUALITY OF LIFE (QOL), WITH IMPROVEMENT IN SUBDOMAINS OF QOL VARYING ACROSS STUDIES. FATIGUE WAS THE MOST COMMONLY MEASURED OUTCOME, AND MOST RCTS CONDUCTED DURING OR AFTER CANCER TREATMENT REPORTED IMPROVEMENTS IN FATIGUE. RESULTS ALSO SUGGESTED THAT YOGA CAN IMPROVE STRESS/DISTRESS DURING TREATMENT AND POST-TREATMENT DISTURBANCES IN SLEEP AND COGNITION. SEVERAL RCTS PROVIDED EVIDENCE THAT YOGA MAY IMPROVE BIOMARKERS OF STRESS, INFLAMMATION, AND IMMUNE FUNCTION. OUTCOMES WITH LIMITED OR MIXED FINDINGS (EG, ANXIETY, DEPRESSION, PAIN, CANCER-SPECIFIC SYMPTOMS, SUCH AS LYMPHEDEMA) AND POSITIVE PSYCHOLOGICAL OUTCOMES (SUCH AS BENEFIT-FINDING AND LIFE SATISFACTION) WARRANT FURTHER STUDY. IMPORTANT FUTURE DIRECTIONS FOR YOGA RESEARCH IN ONCOLOGY INCLUDE: ENROLLING PARTICIPANTS WITH CANCER TYPES OTHER THAN BREAST, STANDARDIZING SELF-REPORT ASSESSMENTS, INCREASING THE USE OF ACTIVE CONTROL GROUPS AND OBJECTIVE MEASURES, AND ADDRESSING THE HETEROGENEITY OF YOGA INTERVENTIONS, WHICH VARY IN TYPE, KEY COMPONENTS (MOVEMENT, MEDITATION, BREATHING), DOSE, AND DELIVERY MODE. 2019 9 2577 22 YOGA FOR GENERALIZED ANXIETY DISORDER: DESIGN OF A RANDOMIZED CONTROLLED CLINICAL TRIAL. GENERALIZED ANXIETY DISORDER (GAD) IS A COMMON DISORDER ASSOCIATED WITH SIGNIFICANT DISTRESS AND INTERFERENCE. ALTHOUGH COGNITIVE BEHAVIORAL THERAPY (CBT) HAS BEEN SHOWN TO BE THE MOST EFFECTIVE FORM OF PSYCHOTHERAPY, FEW PATIENTS RECEIVE OR HAVE ACCESS TO THIS INTERVENTION. YOGA THERAPY OFFERS ANOTHER PROMISING, YET UNDER-RESEARCHED, INTERVENTION THAT IS GAINING INCREASING POPULARITY IN THE GENERAL PUBLIC, AS AN ANXIETY REDUCTION INTERVENTION. THE PURPOSE OF THIS INNOVATIVE CLINICAL TRIAL PROTOCOL IS TO INVESTIGATE THE EFFICACY OF A KUNDALINI YOGA INTERVENTION, RELATIVE TO CBT AND A CONTROL CONDITION. KUNDALINI YOGA AND CBT ARE COMPARED WITH EACH OTHER IN A NONINFERIORITY TEST AND BOTH TREATMENTS ARE COMPARED TO STRESS EDUCATION TRAINING, AN ATTENTION CONTROL INTERVENTION, IN SUPERIORITY TESTS. THE SAMPLE WILL CONSIST OF 230 INDIVIDUALS WITH A PRIMARY DSM-5 DIAGNOSIS OF GAD. THIS RANDOMIZED CONTROLLED TRIAL WILL COMPARE YOGA (N=95) TO BOTH CBT FOR GAD (N=95) AND STRESS EDUCATION (N=40), A COMMONLY USED CONTROL CONDITION. ALL THREE TREATMENTS WILL BE ADMINISTERED BY TWO INSTRUCTORS IN A GROUP FORMAT OVER 12 WEEKLY SESSIONS WITH FOUR TO SIX PATIENTS PER GROUP. GROUPS WILL BE RANDOMIZED USING PERMUTED BLOCK RANDOMIZATION, WHICH WILL BE STRATIFIED BY SITE. TREATMENT OUTCOME WILL BE EVALUATED BI-WEEKLY AND AT 6MONTH FOLLOW-UP. FURTHERMORE, POTENTIAL MEDIATORS OF TREATMENT OUTCOME WILL BE INVESTIGATED. GIVEN THE INDIVIDUAL AND ECONOMIC BURDEN ASSOCIATED WITH GAD, IDENTIFYING ACCESSIBLE ALTERNATIVE BEHAVIORAL TREATMENTS WILL HAVE SUBSTANTIVE PUBLIC HEALTH IMPLICATIONS. 2015 10 2156 17 THE EFFECTS OF THE BALI YOGA PROGRAM FOR BREAST CANCER PATIENTS ON CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING: RESULTS OF A PARTIALLY RANDOMIZED AND BLINDED CONTROLLED TRIAL. COMPLEMENTARY AND ALTERNATIVE MEDICINE HAS BEEN SHOWN TO BE BENEFICIAL IN REDUCING CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING. HOWEVER, CONCLUSIVE RESULTS ARE LACKING IN ORDER TO CONFIRM ITS USEFULNESS. THE PURPOSE OF THIS STUDY WAS TO DETERMINE WHETHER A STANDARDIZED YOGA INTERVENTION COULD REDUCE THESE ADVERSE SYMPTOMS. THIS WAS A PARTIALLY RANDOMIZED AND BLINDED CONTROLLED TRIAL COMPARING A STANDARDIZED YOGA INTERVENTION WITH STANDARD CARE. ELIGIBLE PATIENTS WERE ADULTS DIAGNOSED WITH STAGES I TO III BREAST CANCER RECEIVING CHEMOTHERAPY. PATIENTS RANDOMIZED TO THE EXPERIMENTAL GROUP PARTICIPATED IN AN 8-WEEK YOGA PROGRAM. THERE WAS NO SIGNIFICANT DIFFERENCE BETWEEN THE EXPERIMENTAL AND CONTROL GROUPS ON CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING AFTER 8 WEEKS. RESULTS SUGGEST THE YOGA PROGRAM IS NOT BENEFICIAL IN MANAGING THESE ADVERSE SYMPTOMS. HOWEVER, CONSIDERING PRELIMINARY EVIDENCE SUGGESTING YOGA'S BENEFICIAL IMPACT IN CANCER SYMPTOM MANAGEMENT, METHODOLOGICAL LIMITATIONS SHOULD BE EXPLORED AND ADDITIONAL STUDIES SHOULD BE CONDUCTED. 2017 11 2627 16 YOGA FOR THE MANAGEMENT OF CANCER TREATMENT-RELATED TOXICITIES. PURPOSE OF REVIEW: TO (1) EXPLAIN WHAT YOGA IS, (2) SUMMARIZE PUBLISHED LITERATURE ON THE EFFICACY OF YOGA FOR MANAGING CANCER TREATMENT-RELATED TOXICITIES, (3) PROVIDE CLINICAL RECOMMENDATIONS ON THE USE OF YOGA FOR ONCOLOGY PROFESSIONALS, AND (4) SUGGEST PROMISING AREAS FOR FUTURE RESEARCH. RECENT FINDINGS: BASED ON A TOTAL OF 24 PHASE II AND ONE PHASE III CLINICAL TRIALS, LOW-INTENSITY FORMS OF YOGA, SPECIFICALLY GENTLE HATHA AND RESTORATIVE, ARE FEASIBLE, SAFE, AND EFFECTIVE FOR TREATING SLEEP DISRUPTION, CANCER-RELATED FATIGUE, COGNITIVE IMPAIRMENT, PSYCHOSOCIAL DISTRESS, AND MUSCULOSKELETAL SYMPTOMS IN CANCER PATIENTS RECEIVING CHEMOTHERAPY AND RADIATION AND CANCER SURVIVORS. CLINICIANS SHOULD CONSIDER PRESCRIBING YOGA FOR THEIR PATIENTS SUFFERING WITH THESE TOXICITIES BY REFERRING THEM TO QUALIFIED YOGA PROFESSIONALS. MORE DEFINITIVE PHASE III CLINICAL TRIALS ARE NEEDED TO CONFIRM THESE FINDINGS AND TO INVESTIGATE OTHER TYPES, DOSES, AND DELIVERY MODES OF YOGA FOR TREATING CANCER-RELATED TOXICITIES IN PATIENTS AND SURVIVORS. 2018 12 1239 18 FEASIBILITY OF A MANUALIZED MINDFUL YOGA INTERVENTION FOR PATIENTS WITH CHRONIC MOOD DISORDERS. CHRONIC MOOD DISORDERS POSE AN IMPORTANT MENTAL HEALTH PROBLEM. INDIVIDUALS WITH THESE DISORDERS EXPERIENCE A SIGNIFICANT IMPAIRMENT, OFTEN FAIL TO SEEK HELP, AND THEIR ILLNESSES FREQUENTLY DO NOT RESPOND TO TREATMENT. IT IS THEREFORE IMPORTANT TO DEVELOP INNOVATIVE AND ATTRACTIVE TREATMENTS FOR THESE DISORDERS. MINDFUL YOGA REPRESENTS A PROMISING TREATMENT APPROACH. THIS PILOT STUDY TESTED THE FEASIBILITY OF A 9-WEEK MANUALIZED MINDFUL YOGA INTERVENTION FOR PATIENTS WITH CHRONIC MOOD DISORDERS. ELEVEN PATIENTS RECEIVING STANDARD TREATMENT WERE RECRUITED TO COMPLETE A 9-WEEK MINDFUL YOGA INTERVENTION. QUALITATIVE METHODS WERE USED TO ASSESS PATIENTS' EXPERIENCES OF THE INTERVENTION AND QUANTITATIVE METHODS WERE USED TO ASSESS PSYCHOLOGICAL DISTRESS AND MECHANISMS THAT PLAY A ROLE IN CHRONIC MOOD DISORDERS. EIGHT PATIENTS COMPLETED THE INTERVENTION AND RATED THE OVERALL QUALITY OF THE INTERVENTION WITH A MEAN SCORE OF 8.8 (RANGE OF 8 TO 9, USING A SCALE OF 1 TO 10). ALL PARTICIPANTS REPORTED A REDUCTION IN PSYCHOLOGICAL DISTRESS AND NO ADVERSE EVENTS. AMONG THE MECHANISMS THAT PLAY A ROLE IN CHRONIC MOOD DISORDERS, THE MOST POTENTIALLY PROMISING EFFECTS FROM THE INTERVENTION WERE FOUND FOR WORRY, FEAR OF DEPRESSION AND ANXIETY, RUMINATION, AND AREAS RELATED TO BODY AWARENESS, SUCH AS TRUSTING BODILY EXPERIENCES AND NOT DISTRACTING FROM SENSATIONS OF DISCOMFORT. A 9-WEEK MINDFUL YOGA INTERVENTION APPEARS TO BE A FEASIBLE AND ATTRACTIVE TREATMENT WHEN ADDED TO TREATMENT AS USUAL FOR A GROUP OF PATIENTS WITH CHRONIC MOOD DISORDERS. A RANDOMIZED CONTROLLED TRIAL TO STUDY THE EFFECTS OF MINDFUL YOGA IS RECOMMENDED. 2021 13 1663 20 NATURALISTIC EVALUATION OF AN ADJUNCTIVE YOGA PROGRAM FOR WOMEN WITH SUBSTANCE USE DISORDERS IN INPATIENT TREATMENT: WITHIN-TREATMENT EFFECTS ON CRAVINGS, SELF-EFFICACY, PSYCHIATRIC SYMPTOMS, IMPULSIVITY, AND MINDFULNESS. ADDICTION CONTINUES TO BE A MAJOR PUBLIC HEALTH CONCERN, AND RATES OF RELAPSE FOLLOWING CURRENTLY-AVAILABLE TREATMENTS REMAIN HIGH. THERE IS INCREASING INTEREST IN THE ADJUNCTIVE USE OF MINDFULNESS-BASED INTERVENTIONS, SUCH AS YOGA, TO IMPROVE TREATMENT OUTCOMES. THE CURRENT STUDY WAS A PRELIMINARY NATURALISTIC INVESTIGATION OF A NOVEL TRAUMA-INFORMED YOGA INTERVENTION IN AN INPATIENT TREATMENT PROGRAM FOR WOMEN WITH SUBSTANCE USE DISORDER (SUD). CHANGES AND DIFFERENCES IN SOMATIC SYMPTOMS, PSYCHIATRIC SYMPTOMS, AND PSYCHOLOGICAL MECHANISMS WERE EVALUATED IN WOMEN RECEIVING TREATMENT-AS-USUAL (N = 36) AND TREATMENT-AS-USUAL PLUS THE YOGA INTERVENTION (N = 42). FOR BOTH GROUPS, STATISTICALLY SIGNIFICANT WITHIN-SUBJECTS CHANGES WERE PRESENT FOR SOMATIC AND PSYCHIATRIC SYMPTOMS, CRAVINGS, SELF-EFFICACY, AND MULTIPLE FACETS OF IMPULSIVITY AND MINDFULNESS. COMPARED TO STANDARD TREATMENT ALONE, PARTICIPANTS IN THE TREATMENT PLUS YOGA CONDITION SIGNIFICANTLY IMPROVED IN RANGE OF MOTION AND THE LACK OF PREMEDITATION FACET OF IMPULSIVITY. ALTHOUGH MOST DOMAINS WERE NOT SELECTIVELY AFFECTED, THESE INITIAL WITHIN-TREATMENT FINDINGS IN THIS NATURALISTIC EVALUATION SUGGEST SOME PROMISE FOR ADJUNCTIVE YOGA AND A NEED FOR FURTHER EVALUATION, ESPECIALLY USING LARGER SAMPLES AND LONGER TERM FOLLOW-UP. 2021 14 252 20 A YOGA PROGRAM FOR THE SYMPTOMS OF POST-TRAUMATIC STRESS DISORDER IN VETERANS. THE PURPOSE OF THIS PILOT STUDY WAS TO EVALUATE THE FEASIBILITY AND EFFECTIVENESS OF A YOGA PROGRAM AS AN ADJUNCTIVE THERAPY FOR IMPROVING POST-TRAUMATIC STRESS DISORDER (PTSD) SYMPTOMS IN VETERANS WITH MILITARY-RELATED PTSD. VETERANS (N = 12) PARTICIPATED IN A 6 WEEK YOGA INTERVENTION HELD TWICE A WEEK. THERE WAS SIGNIFICANT IMPROVEMENT IN PTSD HYPERAROUSAL SYMPTOMS AND OVERALL SLEEP QUALITY AS WELL AS DAYTIME DYSFUNCTION RELATED TO SLEEP. THERE WERE NO SIGNIFICANT IMPROVEMENTS IN THE TOTAL PTSD, ANGER, OR QUALITY OF LIFE OUTCOME SCORES. THESE RESULTS SUGGEST THAT THIS YOGA PROGRAM MAY BE AN EFFECTIVE ADJUNCTIVE THERAPY FOR IMPROVING HYPERAROUSAL SYMPTOMS OF PTSD INCLUDING SLEEP QUALITY. THIS STUDY DEMONSTRATES THAT THE YOGA PROGRAM IS ACCEPTABLE, FEASIBLE, AND THAT THERE IS GOOD ADHERENCE IN A VETERAN POPULATION. 2013 15 2485 17 YOGA AS AN ANCILLARY TREATMENT FOR NEUROLOGICAL AND PSYCHIATRIC DISORDERS: A REVIEW. YOGA IS GAINING ACCEPTANCE AS AN ANCILLARY MEDICAL TREATMENT, BUT THERE HAVE BEEN FEW STUDIES EVALUATING ITS THERAPEUTIC BENEFITS IN NEUROLOGICAL AND MAJOR PSYCHIATRIC CONDITIONS. THE AUTHORS REVIEWED THE LITERATURE IN ENGLISH ON THE EFFICACY OF YOGA FOR THESE DISORDERS. ONLY RANDOMIZED, CONTROLLED TRIALS WERE INCLUDED, WITH THE EXCEPTION OF THE ONLY STUDY OF YOGA FOR BIPOLAR DISORDER, WHICH WAS OBSERVATIONAL. TRIALS WERE EXCLUDED IF YOGA WAS NOT THE CENTRAL COMPONENT OF THE INTERVENTION. OF SEVEN RANDOMIZED, CONTROLLED TRIALS OF YOGA IN PATIENTS WITH NEUROLOGICAL DISORDERS, SIX FOUND SIGNIFICANT, POSITIVE EFFECTS. OF 13 RANDOMIZED, CONTROLLED TRIALS OF YOGA IN PATIENTS WITH PSYCHIATRIC DISORDERS, 10 FOUND SIGNIFICANT, POSITIVE EFFECTS. THESE RESULTS, ALTHOUGH ENCOURAGING, INDICATE THAT ADDITIONAL RANDOMIZED, CONTROLLED STUDIES ARE NEEDED TO CRITICALLY DEFINE THE BENEFITS OF YOGA FOR BOTH NEUROLOGICAL AND PSYCHIATRIC DISORDERS. 2012 16 793 24 EFFECT OF YOGA IN THE THERAPY OF IRRITABLE BOWEL SYNDROME: A SYSTEMATIC REVIEW. BACKGROUND & AIMS: THIS REVIEW AIMS TO SYSTEMATICALLY SURVEY THE EFFECTS OF YOGA ON SYMPTOMS OF IRRITABLE BOWEL SYNDROME (IBS), PAIN, QUALITY OF LIFE, MOOD, STRESS, AND SAFETY IN PATIENTS WITH IBS. METHODS: MEDLINE/PUBMED, SCOPUS, THE COCHRANE LIBRARY, CAM-QUEST, CAMBASE, AND INDMED WERE SCREENED THROUGH NOVEMBER 2015. RANDOMIZED CONTROLLED TRIALS COMPARING YOGA WITH USUAL CARE, NONPHARMACOLOGIC, OR PHARMACOLOGIC INTERVENTIONS WERE ANALYZED FOR PATIENTS WITH IBS. PRIMARY OUTCOMES INCLUDED GASTROINTESTINAL SYMPTOMS, QUALITY OF LIFE, AND PAIN. ANXIETY, MOOD, AND SAFETY WERE DEFINED AS SECONDARY OUTCOMES. RISK OF BIAS WAS ASSESSED ACCORDING TO THE COCHRANE COLLABORATION RECOMMENDATIONS. RESULTS: SIX RANDOMIZED CONTROLLED TRIALS WITH A TOTAL OF 273 PATIENTS WERE INCLUDED IN THE QUALITATIVE ANALYSIS. THERE WAS EVIDENCE FOR A BENEFICIAL EFFECT OF A YOGIC INTERVENTION OVER CONVENTIONAL TREATMENT IN IBS, WITH SIGNIFICANTLY DECREASED BOWEL SYMPTOMS, IBS SEVERITY, AND ANXIETY. FURTHERMORE, THERE WERE SIGNIFICANT IMPROVEMENTS IN QUALITY OF LIFE, GLOBAL IMPROVEMENT, AND PHYSICAL FUNCTIONING AFTER YOGA COMPARED WITH NO TREATMENT. TWO RANDOMIZED CONTROLLED TRIALS REPORTED SAFETY DATA STATING THAT NO ADVERSE EVENTS OCCURRED. OVERALL, RISK OF BIAS OF THE INCLUDED STUDIES WAS UNCLEAR. CONCLUSIONS: THE FINDINGS OF THIS SYSTEMATIC REVIEW SUGGEST THAT YOGA MIGHT BE A FEASIBLE AND SAFE ADJUNCTIVE TREATMENT FOR PEOPLE WITH IBS. NEVERTHELESS, NO RECOMMENDATION CAN BE MADE REGARDING YOGA AS A ROUTINE INTERVENTION FOR PATIENTS WITH IBS BECAUSE OF MAJOR FLAWS IN STUDY METHODS. MORE RESEARCH IS NEEDED WITH RESPECT TO A HIGH-QUALITY STUDY DESIGN AND CONSENSUS IN CLINICAL OUTCOME MEASUREMENTS IN IBS. CLINICALTRIALS.GOV NUMBER, NCT02721836. 2016 17 2441 19 YOGA AND SCHIZOPHRENIA-A COMPREHENSIVE ASSESSMENT OF NEUROPLASTICITY: PROTOCOL FOR A SINGLE BLIND RANDOMIZED CONTROLLED STUDY OF YOGA IN SCHIZOPHRENIA. INTRODUCTION: SCHIZOPHRENIA IS ONE OF THE MOST SEVERE MENTAL DISORDERS WITH A PREVALENCE OF ABOUT 1% AND A LEADING CAUSE OF DISABILITY AMONG YOUNG ADULTS. PHARMACOTHERAPY IS THE MAINSTAY IN THE MANAGEMENT OF SCHIZOPHRENIA. HOWEVER, EVEN WITH THE BEST OF MEDICATION, SEVERAL PROBLEMS LIKE REFRACTORINESS, NEGATIVE SYMPTOMS, FREQUENT RELAPSES, AND COGNITIVE IMPAIRMENTS PERSIST. METHODS: THIS IS A RANDOMIZED-CONTROLLED CLINICAL STUDY INCLUDING PATIENTS FROM AN URBAN TERTIARY HOSPITAL AND A SEMI-URBAN COMMUNITY CENTER, WITH A BETWEEN-GROUP, REPEATED-MEASURES, LONGITUDINAL DESIGN. THIS STUDY WILL RECRUIT 160 PATIENTS WITH DSM 5 DIAGNOSIS OF SCHIZOPHRENIA WHO ARE ON STABLE MEDICATION FOR A MINIMUM OF 6 WEEKS; THEY WILL BE RANDOMLY ASSIGNED INTO 2 ARMS VIZ., YOGA THERAPY (YT), AND TREATMENT-AS-USUAL (TAU) WITH 80 PATIENTS IN EACH ARM. PARTICIPANTS WILL UNDERGO CLINICAL, LABORATORY, AND RADIOLOGICAL ASSESSMENTS AT BASELINE AND AT INTERVALS OF 1 MONTH, 3 MONTHS, AND 6 MONTHS FROM THE BASELINE. IT IS HYPOTHESIZED THAT YOGA WILL IMPROVE PSYCHOPATHOLOGY AND EMOTION PROCESSING, INCREASE SERUM BRAIN DERIVED NEUROTROPHIC FACTOR (BDNF) AND PLASMA OXYTOCIN LEVELS AND EFFECT CHANGES IN CEREBRAL ACTIVATION IN AREAS OF THE BRAIN ASSOCIATED WITH SCHIZOPHRENIA. DISCUSSION: THIS STUDY AIMS TO MEASURE THE EFFICACY OF A YOGA-BASED INTERVENTION AS AN ADJUNCT IN PATIENTS WITH SCHIZOPHRENIA AS WELL AS THE MECHANISMS OF THESE EFFECTS. TRIAL REGISTRATION: REGISTERED RETROSPECTIVELY WITH CLINICAL TRIAL REGISTRY - INDIA (CTRI) WITH REGISTRATION NUMBER CTRI/2017/08/009219. 2019 18 133 17 A PRAGMATIC PREFERENCE TRIAL OF THERAPEUTIC YOGA AS AN ADJUNCT TO GROUP COGNITIVE BEHAVIOUR THERAPY VERSUS GROUP CBT ALONE FOR DEPRESSION AND ANXIETY. BACKGROUND: YOGA HAS SEVERAL MECHANISMS THAT MAKE IT A PROMISING TREATMENT FOR DEPRESSION AND ANXIETY, INCLUDING PHYSICAL ACTIVITY, BEHAVIOURAL ACTIVATION, AND MINDFULNESS. FOLLOWING POSITIVE OUTCOMES FROM ADAPTED CBT INTERVENTIONS INCORPORATING MINDFULNESS-BASED PRACTICES, THIS STUDY EXPLORED THE EFFECTS OF A THERAPEUTIC YOGA PROGRAM AS AN ADJUNCT TO GROUP-BASED CBT FOR DEPRESSION OR ANXIETY. METHODS: THIS WAS A PRAGMATIC PREFERENCE TRIAL INVOLVING ADULTS DIAGNOSED WITH DEPRESSION OR ANXIETY IN A REGIONAL PRIMARY MENTAL HEALTHCARE SERVICE (N = 59), COMPARING TRANSDIAGNOSTIC GROUP CBT (N = 27) WITH TRANSDIAGNOSTIC GROUP CBT COMBINED WITH AN ADJUNCT THERAPEUTIC YOGA PROGRAM (N = 32). A PREFERENCE RECRUITMENT DESIGN ALLOWED ELIGIBLE PARTICIPANTS (N = 35) TO SELF-SELECT INTO THE ADJUNCT PROGRAM. THE DEPRESSION ANXIETY STRESS SCALE-21 (DASS) WAS ASSESSED AT BASELINE, POST-INTERVENTION, AND THREE-MONTHS FOLLOW UP. RESULTS: CBT + YOGA WAS AN ACCEPTABLE ALTERNATIVE TO CBT ALONE. SIGNIFICANT REDUCTIONS WERE OBSERVED IN TOTAL DASS SCORES AND THE 3 SUBSCALES OF THE DASS FOR BOTH GROUPS, HOWEVER CBT + YOGA SHOWED SIGNIFICANTLY LOWER DEPRESSIVE AND ANXIETY SYMPTOMS POST-INTERVENTION, COMPARED TO CBT ALONE. CBT + YOGA ALSO SHOWED SUSTAINED REDUCTIONS IN DEPRESSIVE SYMPTOMS OVER THREE-MONTHS, AND MORE RAPID REDUCTIONS IN DEPRESSIVE SYMPTOMS, COMPARED TO CBT ALONE. LIMITATIONS: THESE FINDINGS SHOULD BE CONSIDERED PRELIMINARY DUE TO THE MODERATE SAMPLE SIZE, WITH A RIGOROUS RANDOMISED CONTROL TRIAL NECESSARY TO DEFINITIVELY SUPPORT THE INTEGRATION OF YOGA WITHIN MENTAL HEALTH CARE TO AUGMENT THE BENEFITS AND UPTAKE OF TRANSDIAGNOSTIC CBT FOR DEPRESSION AND ANXIETY. CONCLUSIONS: COMPLEMENTING OTHER MINDFULNESS-BASED PRACTICES, THERAPEUTIC YOGA SHOWS PROMISE AS AN ADJUNCT TO TRANSDIAGNOSTIC CBT. 2022 19 931 23 EFFECTIVENESS OF YOGA THERAPY AS A COMPLEMENTARY TREATMENT FOR MAJOR PSYCHIATRIC DISORDERS: A META-ANALYSIS. OBJECTIVE: TO EXAMINE THE EFFICACY OF YOGA THERAPY AS A COMPLEMENTARY TREATMENT FOR PSYCHIATRIC DISORDERS SUCH AS SCHIZOPHRENIA, DEPRESSION, ANXIETY, AND POSTTRAUMATIC STRESS DISORDER (PTSD). DATA SOURCES: ELIGIBLE TRIALS WERE IDENTIFIED BY A LITERATURE SEARCH OF PUBMED/MEDLINE, COCHRANE CONTROL TRIALS REGISTER, GOOGLE SCHOLAR, AND EBSCO ON THE BASIS OF CRITERIA OF ACCEPTABLE QUALITY AND RELEVANCE. THE SEARCH WAS PERFORMED USING THE FOLLOWING TERMS: YOGA FOR SCHIZOPHRENIA, YOGA FOR DEPRESSION, YOGA FOR ANXIETY, YOGA FOR PTSD, YOGA THERAPY, YOGA FOR PSYCHIATRIC DISORDERS, COMPLEMENTARY TREATMENT, AND EFFICACY OF YOGA THERAPY. TRIALS BOTH UNPUBLISHED AND PUBLISHED WITH NO LIMITATION PLACED ON YEAR OF PUBLICATION WERE INCLUDED; HOWEVER, THE OLDEST ARTICLE INCLUDED IN THE FINAL META-ANALYSIS WAS PUBLISHED IN 2000. STUDY SELECTION: ALL AVAILABLE RANDOMIZED, CONTROLLED TRIALS OF YOGA FOR THE TREATMENT OF MENTAL ILLNESS WERE REVIEWED, AND 10 STUDIES WERE ELIGIBLE FOR INCLUSION. AS VERY FEW RANDOMIZED, CONTROLLED STUDIES HAVE EXAMINED YOGA FOR MENTAL ILLNESS, THIS META-ANALYSIS INCLUDES STUDIES WITH PARTICIPANTS WHO WERE DIAGNOSED WITH MENTAL ILLNESS, AS WELL AS STUDIES WITH PARTICIPANTS WHO WERE NOT DIAGNOSED WITH MENTAL ILLNESS BUT REPORTED SYMPTOMS OF MENTAL ILLNESS. TRIALS WERE EXCLUDED DUE TO THE FOLLOWING: (1) INSUFFICIENT INFORMATION, (2) INADEQUATE STATISTICAL ANALYSIS, (3) YOGA WAS NOT THE CENTRAL COMPONENT OF THE INTERVENTION, (4) SUBJECTS WERE NOT DIAGNOSED WITH OR DID NOT REPORT EXPERIENCING SYMPTOMS OF ONE OF THE PSYCHIATRIC DISORDERS OF INTEREST (IE, SCHIZOPHRENIA, DEPRESSION, ANXIETY, AND PTSD), (5) STUDY WAS NOT REPORTED IN ENGLISH, AND (6) STUDY DID NOT INCLUDE A CONTROL GROUP. DATA EXTRACTION: DATA WERE EXTRACTED ON PARTICIPANT DIAGNOSIS, INCLUSION CRITERIA, TREATMENT AND CONTROL GROUPS, DURATION OF INTERVENTION, AND RESULTS (PRE-POST MEAN AND STANDARD DEVIATIONS, T VALUES, AND F VALUES). NUMBER, AGE, AND SEX RATIO OF PARTICIPANTS WERE ALSO OBTAINED WHEN AVAILABLE. DATA SYNTHESIS: THE COMBINED ANALYSIS OF ALL 10 STUDIES PROVIDED A POOLED EFFECT SIZE OF -3.25 (95% CI, -5.36 TO -1.14; P = .002), INDICATING THAT YOGA-BASED INTERVENTIONS HAVE A STATISTICALLY SIGNIFICANT EFFECT AS AN ADJUNCT TREATMENT FOR MAJOR PSYCHIATRIC DISORDERS. FINDINGS IN SUPPORT OF ALTERNATIVE AND COMPLEMENTARY INTERVENTIONS MAY ESPECIALLY BE AN AID IN THE TREATMENT OF DISORDERS FOR WHICH CURRENT TREATMENTS ARE FOUND TO BE INADEQUATE OR TO CARRY SEVERE LIABILITIES. CONCLUSIONS: AS CURRENT PSYCHOPHARMACOLOGIC INTERVENTIONS FOR SEVERE MENTAL ILLNESS ARE ASSOCIATED WITH INCREASED RISK OF WEIGHT GAIN AS WELL AS OTHER METABOLIC SIDE EFFECTS THAT INCREASE PATIENTS' RISK FOR CARDIOVASCULAR DISEASE, YOGA MAY BE AN EFFECTIVE, FAR LESS TOXIC ADJUNCT TREATMENT OPTION FOR SEVERE MENTAL ILLNESS. 2011 20 644 17 DOES YOGA HAVE A ROLE IN SCHIZOPHRENIA MANAGEMENT? PURPOSE OF REVIEW: TO REVIEW THE EFFICACY OF ADD-ON YOGA THERAPY IN IMPROVING SYMPTOMS OF SCHIZOPHRENIA AND QUALITY OF LIFE AND EXAMINE THE POSSIBLE UNDERLYING BIOLOGICAL MECHANISMS OF YOGA IN SCHIZOPHRENIA. RECENT FINDINGS: QUALITY OF LIFE, COGNITIVE SYMPTOMS, AND NEGATIVE SYMPTOMS HAVE BEEN FOUND TO IMPROVE WITH ADD-ON YOGA THERAPY IN SCHIZOPHRENIA (POOLED MEAN EFFECT SIZE 0.8, 0.6, AND 0.4, RESPECTIVELY). YOGA ALSO SEEMS TO HAVE A SMALL EFFECT ON IMPROVING POSITIVE SYMPTOMS. LESS EXPLORED AREAS INCLUDE ADVERSE EFFECTS OF YOGA ITSELF AS WELL AS ITS EFFECTS ON ANTIPSYCHOTIC-INDUCED COMPLICATIONS. PRELIMINARY FINDINGS SUGGEST THAT THE EFFECTS OF YOGA MAY BE MEDIATED BY NEUROHORMONAL MECHANISMS AND FUNCTIONAL CHANGES IN BRAIN ACTIVITY. ADD-ON YOGA THERAPY IS A POTENTIAL TREATMENT OPTION FOR IMPROVING QUALITY OF LIFE, COGNITIVE SYMPTOMS, AND NEGATIVE SYMPTOMS IN SCHIZOPHRENIA. FUTURE STUDIES SHOULD EXPLORE EFFICACY IN MULTICENTRIC TRIALS AS WELL AS POSSIBLE NEUROBIOLOGICAL CHANGES UNDERLYING THE EFFECTS. 2020